Catalyst Wire Dossier Catalyst Wire Dossier

V212/Heat-Treated Varicella-Zoster Virus Vaccine

V212 · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V212/Heat-Treated Varicella-Zoster Virus Vaccine, covering 2019-04-16 to 2019-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002) [Phase 1]

See pricing